Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AtLaS: Simplification to Atazanavir/Ritonavir + Lamivudine in HIV
NCT00885482Phase 4Completed
- Sponsor
- Università Cattolica del Sacro Cuore
- Start
- May 2009
- Primary completion
- May 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of atazanavir, lamivudine, ritonavir in human immunodeficiency virus infection (HIV), sponsored by Università Cattolica del Sacro Cuore. Started May 2009; status: completed.
02
Drugs
atazanavirlamivudineritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00885482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885482.